R.grid is an innovative startup revolutionizing the landscape of clinical trials with its automation engine. Founded in 2019 and based in the United Kingdom, R.grid's mission is to expedite and enhance the efficacy of clinical trials by leveraging smart software to automate administrative tasks throughout the entire trial life cycle. Their comprehensive solutions include TrialEngine for clinical trial management and Inclusive for patient and community engagement, catering to various trial types and therapeutic areas. The startup recently secured a noteworthy £1.20M Seed Round investment on 09 March 2020, which was backed by prominent investors such as Ada Ventures, Ascension Ventures (UK), and Impact X Capital Partners. By addressing the need for admin-free clinical trials and streamlining processes, R.grid is poised to make a significant impact on the industry. Their cutting-edge approach has the potential to enhance the efficiency and success rates of clinical trials, offering a promising investment opportunity for venture capitalists seeking to support groundbreaking innovations in the healthcare and technology sectors. Interested investors should keep a close eye on R.grid as they continue to disrupt and improve the clinical trial landscape.
No recent news or press coverage available for R.grid.